InterCure Ltd. (NASDAQ:INCR) Short Interest Down 21.9% in October

InterCure Ltd. (NASDAQ:INCRGet Free Report) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 13,900 shares, a drop of 21.9% from the October 15th total of 17,800 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average daily trading volume, of 28,600 shares, the days-to-cover ratio is presently 0.5 days.

Institutional Investors Weigh In On InterCure

Several large investors have recently bought and sold shares of the business. Tidal Investments LLC purchased a new position in shares of InterCure during the 1st quarter valued at $883,000. Renaissance Technologies LLC lifted its stake in shares of InterCure by 30.9% in the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after purchasing an additional 10,700 shares during the last quarter. AdvisorShares Investments LLC purchased a new position in shares of InterCure in the 2nd quarter worth approximately $218,000. Finally, Jane Street Group LLC bought a new position in shares of InterCure during the 3rd quarter valued at approximately $49,000. 8.34% of the stock is currently owned by institutional investors.

InterCure Trading Down 5.9 %

Shares of NASDAQ:INCR traded down $0.07 during midday trading on Friday, reaching $1.17. The company’s stock had a trading volume of 142,958 shares, compared to its average volume of 37,305. InterCure has a 12-month low of $1.06 and a 12-month high of $3.72. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15. The firm has a 50 day moving average of $1.76 and a 200-day moving average of $2.21.

InterCure Company Profile

(Get Free Report)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

Recommended Stories

Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.